CuResponse
Mr. Sascha Bucher is a co-founder and Partner at Forty51 ventures, a Biotech VC fund in Europe focused on venture formation. Previously, he was Partner and Managing Director of Investments at Roivant Sciences and Head of Europe. Before that Sascha worked for Roche in numerous Business and Corporate Development functions including as Deputy Head of Global M&A.
This person is not in the org chart
This person is not in any offices
CuResponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.